The purpose of this visiongain report is to examine the commercial prospects of nanotechnology in medicine – the fast-developing and increasingly lucrative field of nanomedicine.
Nanotechnology has great potential to benefit - even revolutionise - the pharmaceutical, medical devices, diagnostics and imaging sectors.
Visiongain predicts that nanomedicine will exhibit strong growth in all sectors from 2006-2011, leading to multi-billion dollar revenues.
Key technology platforms such as nanocrystals, nanotubes, dendrimers, fullerenes, quantum dots and molecular scaffolding will drive that market expansion.
Nanomedicine 2006-2011 examines the nanomedical sector critically through comprehensive primary and secondary research, including interviews with key figures in industry and academia, reports and policy documents, nanotechnology conference proceedings, business/industry news and consultation with bodies promoting nanotechnology.
Visiongain applied techniques such as financial forecasting, SWOT analysis and qualitative projections to provide a comprehensive market report with detailed analyses and informed opinion.
In particular, this report concentrates on the following essential aspects of nanotechnology in the healthcare industry:Technologies that drive nanomedicine Key players in nanomedicine Revenue trends for nanotechnology in healthcare between 2006-2011 Projected timetables for major developments up to 2020 Drivers and opportunities in nanomedicine Restraints and threats in nanomedicine Funding and governmental policy in nanomedicine Venture capital in nanomedicine Regulation, safety and ethics of nanotechnology in medicine An assessment of relevant business models and issues A geographical breakdown of the world market for nanomedicine in 2011Why you should buy this report To receive a comprehensive analysis of the prospects of the world nanomedical sector from 2006-2011 To find out predicted revenues, growth rates and market shares for sectors within nanomedicine from 2006-2011 To determine the forces that influence nanotechnology with medical applications: Competitive characteristics of the market Regulatory, funding and societal issuesDrivers and restraints Strengths, weaknesses, opportunities and threats To find out where nanotechnology in medicine is heading - both technologically and commercially - in the mid-to-long-term periods as well